The Journal of Experimental Medicine
ISSN 0022-1007 · Rockefeller University Press · United States · active 1863–2026
Metrics
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.
Indexing & access
Access status: unknown. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is The Journal of Experimental Medicine a predatory journal?
Our screening does not flag The Journal of Experimental Medicine. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, Web of Science, PubMed, which is a positive signal.
Is The Journal of Experimental Medicine indexed in Scopus or Web of Science?
Per our venue index, The Journal of Experimental Medicine appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is The Journal of Experimental Medicine's impact?
Papers in The Journal of Experimental Medicine are cited about 8.3 times each within two years of publication, and Scimago places it in Q1, with an h-index of 648. This is not a Clarivate Journal Impact Factor — we neither compute nor license that metric — and a citation rate is a property of a field as much as of a journal.
Is The Journal of Experimental Medicine open access?
We hold no reliable open-access classification for The Journal of Experimental Medicine. Check the journal's own site for its access model and any article processing charge.
Similar venues
- ImmunityQ1 · Cell Press
- Nature reviews. ImmunologyQ1 · Nature Portfolio
- Cellular and Molecular ImmunologyQ1 · Springer Nature
- Science Translational MedicineQ1 · American Association for the Advancement of Science
- Science ImmunologyQ1 · American Association for the Advancement of Science
- Seminars in ImmunopathologyQ1 · Springer Science+Business Media